...
首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >Antidiabetic Activity of Ethanolic Extracts of Rhyncosia beddomei and Glycosmis pentaphylla in Alloxan-induced Diabetic Rats
【24h】

Antidiabetic Activity of Ethanolic Extracts of Rhyncosia beddomei and Glycosmis pentaphylla in Alloxan-induced Diabetic Rats

机译:臭豆根和五糖多糖的乙醇提取物对四氧嘧啶致糖尿病大鼠的抗糖尿病作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The objective of the study is to evaluate the anti-diabetic activity of ethanolic extract of Rhyncosia beddomei and ethanolic extract of Glycosmis pentaphylla leaves in alloxan-induced diabetes in adult male wistar albino rats. The effect of ethanolic extract of Rhyncosia beddomei (EERB) and ethanolic extract of Glycosmis pentaphylla (EEGP) on change in blood glucose level, lipid metabolism and histology of fat were examined in the study. Alloxan-induced diabetic adult male wistar albino rats were administered ethanolic extract (200 and 400 mg/Kg, p.o) of Rhyncosia beddomei (EERB) and Glycosmis pentaphylla (EEGP) or standard drug Glibenclamide 2.5 mg/kg or normal control (0.9% Saline) or diabetic control group (Alloxan-induced diabetic rats). The blood glucose levels of rats were recorded after single dose of test and standard drug administration at 0, 1, 2, 4 & 8 hrs and multi dose drug administration for 10 days in each group. Blood glucose levels were recorded at 0, 3, 7 and 10th day of test drug administration. After the last test drug administration i.e. on 11th day of study, animals were sacrificed and performed the evaluation activities. Alloxan-induced diabetes control group animals showed statistically significant increase in blood glucose levels, total cholesterol, triglycerides, LDL-C, VLDL-C and statistically significant decrease in HDL-C as compared to normal group animals. The alloxan-induced animals received EERB (200 & 400 mg/kg) and EEGP (200 & 400 mg/kg) showed decrease in glucose levels, total cholesterol, triglycerides, LDL-C, VLDL-C and statistically significant increase in HDL-C as compared to alloxan-induced diabetes control group animals along with standard group (Glibenclamide 5mg/Kg) animals. The body weight of EERB and EEGP 200 & 400 mg/kg rats showed significantly elevated. In conclusion, the results of diabetic study indicated that test extracts of Rhyncosia beddomei and Glycosmis pentaphylla have a beneficial effect on normalizing glucose level in alloxan‐induced induced diabetic rats. This suggests the efficacy of Rhyncosia beddomei and Glycosmis pentaphylla in the maintenance of glucose homeostasis and may be used as a therapeutic agent in the management of diabetes mellitus.
机译:这项研究的目的是评估成年雄性维斯塔白化病大鼠的四核仁乙醇提取物和五糖糖叶乙醇提取物在四氧嘧啶诱导的糖尿病中的抗糖尿病活性。本研究研究了根瘤菌乙醇提取物(EERB)和五糖糖醇提取物(EEGP)对血糖水平,脂质代谢和脂肪组织学变化的影响。给四氧嘧啶诱导的糖尿病成年雄性Wistar白化病雄性大鼠施用乙醇提取物(200和400 mg / Kg,口服)Rhyncosia beddomei(EERB)和Glycosmis pentaphylla(EEGP)或标准药物Glibenclamide 2.5 mg / kg或正常对照组(0.9%生理盐水) )或糖尿病对照组(四氧嘧啶诱发的糖尿病大鼠)。每组分别在0、1、2、4和8小时进行单次测试和标准药物给药后,连续10天记录大鼠的血糖水平。在试验药物给药的第0、3、7和10天记录血糖水平。在最后一次测试药物给药后,即在研究的第11天,处死动物并进行评估活动。与正常组动物相比,四氧嘧啶诱导的糖尿病对照组动物显示出血糖水平,总胆固醇,甘油三酸酯,LDL-C,VLDL-C的统计学显着升高,而HDL-C的统计学显着降低。接受四氧嘧啶诱导的动物接受EERB(200和400 mg / kg),EEGP(200和400 mg / kg)显示葡萄糖水平,总胆固醇,甘油三酸酯,LDL-C,VLDL-C降低,而HDL-显着增加与四氧嘧啶诱导的糖尿病对照组动物以及标准组(格列本脲5mg / Kg)动物相比,C。 EERB和EEGP 200和400 mg / kg大鼠的体重明显升高。总而言之,糖尿病研究的结果表明,贝氏Rhyncosia beddomei和五糖多糖Glycosmis pentaphylla的测试提取物对归四氧嘧啶诱导的糖尿病大鼠的血糖水平正常化具有有益的作用。这暗示了多毛Rhyncosia beddomei和Glycosmis pentaphylla在维持葡萄糖稳态方面的功效,可以用作治疗糖尿病的治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号